The primary aim of this prospective observational study is to investigate mHLA-DR in a hospital cohort and to integrate mHLA-DR status into routine blood count analysis.
Conditions
Interventions
Group 1: The primary aim of this prospective observational study is to investigate mHLA-DR in a hospital cohort and to integrate mHLA-DR status into routine blood count analysis. The study pursues bot
Sponsors
Universitätsmedizin Göttingen
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - Patients receiving outpatient or inpatient treatment at the University Medical Center Göttingen (UMG) - Patients requiring a blood sample, including a complete blood count or immunological status - Age = 18 years
Exclusion criteria
Exclusion criteria: - Missing written informed consent - Age < 18 years - Pregnant individuals
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| mHLA-DR as a measurement parameter (antibodies/cell) for assessing the normal distribution and correlation of mHLA-DR in the context of various disease patterns. | — |
Secondary
| Measure | Time frame |
|---|---|
| Differential blood count, Cellular immune status (FACS analysis) Humoral immune status, including markers such as interleukin-6, ferritin, C-reactive protein, etc.; Clinical data collected as part of routine procedures, such as ICU scores, disease severity scores, etc.; Clinical course data, including disease progression, secondary infections, etc. | — |
Countries
Germany
Contacts
Public ContactMartin Sebastian Winkler
Universitätsmedizin Göttingen
Outcome results
None listed